Biopharmaceutical company Actinium Pharmaceuticals has received notice of patent allowance for an application covering the treatment of metastatic solid cancers with alpha emitting isotopes. The patent application 'Alpha Emitting ...
Tags: Actinium, Cancer Treatment
Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...
Tags: Curis, Erivedge Anti-Cancer Drug
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has announced positive opinion for conditional approval of Curis' Erivedge in European Union. Erivedge (vismodegib) is used to treat adults with ...
Pfizer has received breakthrough therapy designation from the United States Food and Drug Administration (FDA) for its investigational compound Palbociclib, a potential treatment for patients with breast cancer. The breakthrough therapy ...
Tags: Cancer Drug, Pfizer, Therapy Designation
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
Researchers from the Universities of Dundee, Glasgow and Strathclyde have been awarded pound 691,000 as part of the first wave of funding made available through Prostate Cancer UK’s ambitious new research strategy. A colossal pound ...
Tags: Universities of Dundee, Researchers, Prostate Cancer UK
GlaxoSmithKline (GSK) has submitted marketing authorisation application, to the European Medicines Agency, for trametinib (MEK) as monotherapy and dabrafenib (BRAF)/MEK combination therapy in metastatic melanoma. The application was ...
Tags: GSK, metastatic melanoma therapy, Medicines
Clinical research and service provider GeneDiagnostics has entered into an agreement to distribute WILEX's serum HER-2/neu ELISA test in China. The FDA-approved and CE-marked biomarker test measures serum HER-2/neu protein levels and ...
Tags: Clinical research, GeneDiagnostics, WILEX, serum HER-2/neu ELISA test
The USFDA has accepted for filing Astellas Pharma's supplemental new drug application (sNDA) for Tarceva (erlotinib) tablets for a genetically distinct form of advanced lung cancer. Astellas is seeking approval to use Tarceva as the ...
NanoSight, leading manufacturers of unique nanoparticle characterisation technology, reports on the breakthrough cancer metastasis research of Dr Hector Peinado Selgas and Dr David Lyden's research team from Weill Cornell Medical College. ...
Tags: NanoSight, cancer metastasis, characterisation technology
The European Commission (EC) has approved broader indication of Janssen-Cilag International's oral, once-daily medication Zytiga (abiraterone acetate). Licence extension includes the use of Zytiga as a combination therapy along with ...
Tags: Zytiga, Janssen Europe, medical
Sky Ridge Medical Center in Colorado, US, has initiated the FDA-approved Delcath Systems' expanded access program (EAP) to provide US patients access to second-generation hemofiltration cartridge of Delcath's proprietary chemosaturation ...
Tags: Sky Ridge Medical Cente, US, FDA, Delcath Systems, EAP
Dendreon Corporation has sold its immunotherapy manufacturing facility (IMF) in Morris Plains, New Jersey, US, to Novartis Pharmaceuticals for $43m. In early 2012, Dendreon had decided to bring down Provenge production at the facility as ...
Tags: Novartis, Dendreon immunotherapy, manufacturing facility, Medicine
OncoSec Medical has obtained ISO 13485 quality management system (QMS) certification for the design, development, manufacture, and distribution of its electroporation device including the OncoSec medical system (OMS). Currently being used ...
Tags: OncoSec Medical, OncoSec medical system, OMS